Fiber

People who eat the most fiber die less often of almost everything, and the more they eat, the bigger the gap. The awkward part is that no trial has ever managed to show that adding fiber causes the benefit — and one trial came out the wrong way.

Dietary fiber is the part of plant food your own enzymes cannot digest. Some of it dissolves and forms a gel that slows digestion; some passes through largely intact; some is fermented by gut bacteria into short-chain fatty acids. The evidence that fiber-rich diets track with longer, healthier lives is among the most consistent in nutrition — and the evidence that isolated fiber does anything to hard outcomes is close to nonexistent. Holding both facts at once is the whole art of reading this literature.

What the evidence says

Strong:

  • Higher fiber intake is associated with roughly 15–30% lower risk (about 31% for coronary heart disease mortality, the largest single effect) of all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer, across 185 prospective studies and roughly 135 million person-years. Certainty on GRADE — the standard system for rating how much confidence a body of evidence deserves — is moderate (low for stroke), the highest any carbohydrate-quality marker achieves.[1]
  • A 2025 umbrella review — a review of other reviews — pooled 33 meta-analyses covering 38 outcomes and 17.2 million people, and graded each association on its own credibility ladder — a different scale from GRADE above, ranking how believable an observational association is rather than how good the underlying evidence is. Three outcomes reached its top "convincing" tier: cardiovascular-disease mortality, pancreatic cancer, and diverticular disease. All-cause mortality, cardiovascular disease, coronary heart disease, and ovarian cancer landed one rung below, at "highly suggestive."[2] Note what this does and does not do: it is an umbrella review of observational meta-analyses, so it makes the association harder to dismiss without making it causal. Note also how narrow the top of that ladder is. Sixteen of the 38 outcomes reached only the third tier and six the weakest; nine showed no significant inverse association at all; and just six of the 33 pooled meta-analyses were rated high quality. Colorectal cancer and type 2 diabetes — two of the outcomes this page leads with — are in neither of the top two tiers.
  • For many outcomes, the dose-response is approximately linear with no plateau within the observed range: each extra 8 g/day is associated with 7% lower all-cause mortality.[3]
  • Viscous fibers lower LDL cholesterol — the "bad" cholesterol fraction that drives arterial plaque — modestly but reliably in randomized trials. This is a genuine causal effect, but on a surrogate marker — a lab value that stands in for the disease you actually care about.[4]

Moderate:

  • WHO's 2023 guideline makes a strong recommendation on moderate-certainty evidence: at least 25 g/day of naturally occurring fiber, from food.[5]

Weak / preliminary:

  • Every hard-outcome number above is observational. Fiber intake travels with almost everything else that makes people healthy — an overall better diet, more exercise, less smoking, higher socioeconomic status.

Caution:

  • No randomized trial has shown that increasing fiber reduces mortality or cardiovascular events, and the cancer-prevention trials in ordinary adults have found no benefit either. Several good ones tried and failed.[6] The one randomized cancer signal anywhere in this literature comes from a hereditary-cancer population: in the CAPP2 trial, run in people with Lynch syndrome — an inherited condition that sharply raises the risk of bowel and several other cancers — 30 g/day of resistant starch left colorectal cancer — the trial's own primary endpoint — untouched, but over follow-up of up to 20 years the treated carriers developed about half as many other Lynch-syndrome cancers as controls (27 against 48, hazard ratio 0.54), most of the difference being 5 upper-gastrointestinal cancers against 21.[7]
  • Blanket "eat more fiber" advice is actively wrong for some people with irritable bowel syndrome (IBS). The fiber that helps is soluble and gel-forming; insoluble bran does not help, and gastroenterology guidelines now say so.[8]
  • WHO records one undesirable effect alongside its recommendation: a signal of higher endometrial-cancer risk at higher fiber intakes, which it grades very-low-certainty — the weakest rating it issues — while finding no other harm at intakes of at least 25 g/day.[9]

What the cohorts show

Evidence: Moderate — large, consistent, dose-dependent, and entirely observational.

The anchor is a WHO-commissioned series covering 185 prospective studies and 58 trials.[10] Comparing the highest fiber eaters with the lowest, the risk of dying of anything at all runs about 15% lower, and of coronary heart disease about 31% lower. In the table, a relative risk of 0.85 means 15% lower risk; the range beside it is the 95% confidence interval — where the true value most plausibly sits. When that range crosses 1.00, the result is compatible with no effect at all.

OutcomeRelative risk (highest vs lowest intake)GRADE
All-cause mortality0.85 (0.79–0.91)Moderate
Coronary heart disease — mortality0.69 (0.60–0.81)Moderate
Coronary heart disease — incidence0.76 (0.69–0.83)Moderate
Stroke incidence0.78 (0.69–0.88)Low
Type 2 diabetes0.84 (0.78–0.90)Moderate
Cancer mortality0.87 (0.79–0.95)Moderate
Colorectal cancer0.84 (0.78–0.89)Moderate

The dose-response matters more than the headline. Every additional 8 g/day is associated with roughly 7% lower all-cause mortality (RR 0.93, 95% CI 0.90–0.95), 19% lower coronary heart disease, 15% lower type 2 diabetes, and 8% lower colorectal cancer.[11] Fitting the data with a flexible curve rather than a straight line found no plateau in many of the relationships — the curves were still falling at the top of the observed range, which is as far as the data go. Studies thin out above 30 g/day and become scarce above 40, so "no plateau" means none has been seen, not that none exists.[12] A separate analysis comparing intake bands found that 25–29 g/day gave the greatest benefit across the most outcomes — 6 of 7 critical ones, against 4 of 7 at 20–24 g and 3 of 7 at 15–19 g — and the authors still treat it as a floor rather than an optimum, noting that higher intakes likely confer further benefit. The two findings fit together: 25–29 g is where the observed benefit is largest, not where it stops growing.[13]

Independent analyses agree. Each 7 g/day of fiber is associated with 9% lower cardiovascular disease risk.[14] Each 10 g/day is associated with 10% lower colorectal cancer risk, pooled across nearly two million people with zero heterogeneity between studies.[15] Whole grains — the food, not the isolated nutrient — show associations at least as strong: three servings a day tracks with 22% lower cardiovascular disease and 17% lower all-cause mortality, while for refined grains and white rice there is little evidence of any association.[16]

Two honest footnotes the enthusiastic version of this story leaves out. The coronary-mortality analysis showed detectable publication bias — the tell-tale pattern left when studies finding nothing go unpublished, which inflates whatever survives. The authors tested for it by estimating what the missing studies would have shown, and the pooled result held its direction and significance either way, so this is a caveat on the size of that particular effect rather than on whether it exists. And more than half the variation between the stroke studies was unexplained disagreement rather than chance, meaning those studies were not really measuring the same thing.[17]

And now the problem: the trials

Evidence: Strong that the trials are null; Weak that the trials settle the question.

If fiber caused these benefits, trials should show it. They don't.

Colorectal cancer is the sharpest test, because you can randomize people with a history of adenomas — the precursor polyps — and watch whether fiber stops them coming back. Three trials did exactly that, and all reported in 2000:

  • The Polyp Prevention Trial put 2,079 people on a low-fat, high-fiber, high-fruit-and-vegetable diet for four years. Adenoma recurrence: 39.7% in the intervention arm versus 39.5% in controls — a relative risk of 1.00 (0.90–1.12). Not merely non-significant. Flat.[18]
  • The Wheat Bran Fiber trial compared a 13.5 g/day wheat-bran supplement against 2 g/day. Recurrence ran about 8% lower on the high dose (47.0% against 51.2%), but the result was equally compatible with no effect at all — no significant difference (odds ratio 0.88, 95% CI 0.70–1.11).[19]
  • A European trial gave 3.5 g/day of ispaghula husk (psyllium) and found the odds of adenoma recurrence went up by roughly two-thirds (odds ratio 1.67, 95% CI 1.01–2.76 — just clearing the threshold for significance).[20]

Cochrane pooled the randomized evidence — five trials, 3,641 participants, two to four years — and found nothing — a 4% difference well inside the range expected from chance (relative risk 1.04, 95% CI 0.95–1.13). If anything the review leans the other way: in the two trials that also counted colorectal cancers, not just polyps, there were more cancers in the fiber arms than the control arms, 12 per 1,000 against 4, on a total of 2,794 people and a handful of events. That is a fragile finding on low-quality evidence, and the reviewers say plainly that with the dropout rates involved none of their results can be considered robust.[21]

Cardiovascular disease is worse still. The Cochrane review of fiber for preventing cardiovascular disease found 23 randomized trials — and not one of them reported a single cardiovascular event or death. Most ran under 12 weeks. The entire randomized evidence base for fiber and heart disease consists of surrogate markers, where it shows small, real effects: total cholesterol down 0.23 mmol/L, LDL down 0.14 mmol/L.[22] That review closed its literature search in January 2015 and has not been updated since — worth knowing, though the picture has not improved on the treatment side either: a 2022 review of fiber in people who already have cardiovascular disease or high blood pressure, searching to mid-2021, found 12 randomized trials in 878 people, again with no event or mortality outcome among them.[23]

The one genuine randomized hard-endpoint test of raising fiber was the DART trial in 2,033 men recovering from a heart attack. The arm advised to increase cereal fiber had slightly higher all-cause mortality than the arm that wasn't (non-significant). Only the fish advice helped.[24]

And the largest long-running dietary trial, the Women's Health Initiative — 48,835 postmenopausal women, mean 8.1 years on a low-fat, higher-fiber, higher-fruit-and-vegetable pattern — came back null on every endpoint it was designed to test. Cardiovascular disease moved by 2%, well inside the range expected from chance (hazard ratio 0.98, 95% CI 0.92–1.05 — a hazard ratio is the same idea as the relative risks above, applied to the rate at which events occur over time)[25]; colorectal cancer drifted 8% the wrong way, with an interval that still allowed a modest real reduction (HR 1.08, 0.90–1.29)[26]; breast cancer came closest to a signal at 9% lower, but its interval still touched 1.0 (HR 0.91, 0.83–1.01)[27].

How to hold both facts

Evidence: this section is argument about the evidence, not a claim of its own.

The temptation is to pick a side. Resist it, because the trials are weaker tests than they look:

  • Adenoma recurrence is a surrogate, not cancer, over 3–4 years — against a disease that takes decades to develop.
  • Confidence intervals are wide. The wheat-bran lower bound of 0.70 still permits a 30% reduction in the odds of recurrence — about 17% in plain risk terms, which is about the size of the association the cohorts report for colorectal cancer. These trials failed to demonstrate benefit; they did not demonstrate its absence.
  • The dietary-pattern trials barely changed diets. A year in — the point of best adherence — the Women's Health Initiative's intervention arm was eating 18.3 g of fiber a day against the comparison arm's 15.1, a gap of about 3 g, and the intervention arm never got past 19 g even at its best.[28] The trial's fat contrast decayed from there, so 3 g is an upper bound rather than a sustained one. Its nulls are a poor test of fiber specifically. It was never a fiber trial.
  • The sharpest tests were supplements, not food. The two trials with the cleanest fiber contrast — wheat bran and psyllium, in a sachet — are the ones furthest from lentils. The randomized evidence is cleanest exactly where it is least relevant to how people eat.

But the cohorts are weaker than they look, too. Fiber intake is entangled with everything else that makes people healthy, and no amount of statistical adjustment fully removes that.

The position the evidence actually licenses is narrower than either camp wants: eat fiber-rich whole foods, because the association is strong, dose-dependent, and consistent — but do not believe that isolated fiber has been shown to prevent disease in ordinary adults, because it hasn't, and in one trial it went the wrong way. WHO drew precisely this line: its 25 g/day recommendation explicitly covers "naturally occurring dietary fibre as consumed in foods," and explicitly excludes extracted, synthetic, and added fiber — supplements, capsules, and powders.[29]

That is not an accident of drafting. It is the world's normative guideline body declining to extend its recommendation past its evidence.

Which fiber does what

Evidence: Strong for viscous fiber and cholesterol; Weak for everything downstream of fermentation.

The old soluble/insoluble split is a poor guide. What actually predicts an effect is viscosity (does it form a gel?) and fermentability (do gut bacteria eat it?) — and the two properties do different jobs, sometimes at each other's expense, since a fiber that gets fermented away in the first stretch of the colon is no longer there to do the physical work.[30][31]

Viscous fibers lower cholesterol. This is the one place isolated fiber has clean randomized evidence. Oat beta-glucan at a median 3.5 g/day lowers LDL by 0.19 mmol/L (95% CI 0.14–0.23) — on a typical starting level, something like 5% — pooled across 58 trials in 3,974 people, though the trials disagree with each other a great deal, which is worth knowing before treating that figure as precise.[32] An earlier meta-analysis of 28 trials at 3 g/day or more put the fall somewhat larger, at 0.25 mmol/L.[33] Psyllium does more — LDL down 0.33 mmol/L across 28 trials in 1,924 people, and it moves apolipoprotein B (apoB), the count of atherogenic particles, by 0.05 g/L.[34] That apoB result is the strongest randomized evidence anywhere on this page — high certainty on the GRADE scale, higher than the LDL finding it sits beside. Two caveats keep it in proportion. Those trials used a median of about 10 g/day against beta-glucan's 3.5 g, so part of the gap is dose rather than fiber. And the older psyllium meta-analysis, which reported a smaller fall of 0.28 mmol/L with a clear dose-response from 3 to 20 g/day, was confined to people who already had raised cholesterol, making it a treatment effect rather than a prevention one.[35] Beta-glucan and psyllium both work by trapping bile acids in a gel so they're excreted rather than recycled, forcing the liver to pull cholesterol from the blood to make more — and in a randomized crossover trial psyllium also lowered the fraction of cholesterol absorbed, though the absolute amount absorbed did not change.[36] Real, modest, and worth knowing if you are managing cholesterol.

Fermentable fibers feed the microbiome. Inulin, resistant starch (starch that escapes digestion in the small intestine and reaches the colon intact), and the fibers in legumes and whole grains are broken down by colonic bacteria into short-chain fatty acids, principally butyrate — the main fuel of the cells lining your colon, and the mechanistic heart of most fiber enthusiasm. That story is covered under dysbiosis. Read it with the species gap in mind: a great deal of the butyrate literature is mouse work. The human trials that exist are not encouraging. Pooling 55 randomized trials of inulin-type fructans in 2,518 people, the effects on LDL cholesterol, triglycerides and weight were small and rated low or very-low certainty, with little to no effect on blood sugar, waist circumference or blood pressure.[37]

Fiber is not a natural Ozempic. The claim has a real basis. One of the short-chain fatty acids, propionate, makes cells in the colon wall release GLP-1 and PYY, the gut hormones that signal fullness. The best human test used an engineered fiber that carries extra propionate straight to the colon. In 20 volunteers, a single 10 g dose roughly tripled the GLP-1 response, and they ate about 14% less at a later test meal. Over 24 weeks in overweight adults, 1 of 25 people taking it gained 3% or more of their body weight, against 6 of 24 taking plain inulin — a significant difference, though the 1.4 kg gap in average weight was not.[38] Note what the comparison group was eating: ordinary fermentable fiber, which did not have this effect. And the body's own GLP-1 is broken down within minutes, while semaglutide is built to last a week. Eat fiber for the reasons on this page, not as a substitute for the drug.

Bulking fibers move things along. Wheat bran and cellulose are neither viscous nor readily fermented; they add mass and speed transit. Useful for regularity, and — as the trials above showed — without any demonstrated benefit for preventing polyps.

So there is no single "best fiber." Beta-glucan and psyllium for lipids; a broad mix of plants for the microbiome; and for the mortality association, no isolated fiber at all — the exposure that carries it is whole food.

How much, and from what

Evidence: Strong — these are measured food composition values and national intake surveys, not inference.

On average Americans eat about 16 g/day — 18 for males and 15 for females, on a national survey that counts everyone from age two up, so adult-only averages run a little higher.[39] Against a target of 25–30 g or more, that is the gap worth closing, and it closes faster than people expect, because legumes are extraordinary and everything else is incremental.

FoodPortionFiber
Split peas, cooked1 cup (~195 g)~16 g
Lentils, cooked1 cup (~200 g)~16 g
Black beans, cooked1 cup (~170 g)~15 g
Chickpeas, cooked1 cup (~165 g)~12 g
Artichoke1 medium (~120 g)~7 g
Chia seeds30 g (~2½ tbsp)~10 g
Avocado1 medium (~135 g, flesh only)~9 g
Raspberries1 cup (~125 g)~8 g
Pear, with skin1 medium (~180 g)~5.5 g
Oatmeal, cooked1 cup (~235 g)~4 g
Broccoli, cooked1 cup (~155 g)~5 g
Apple, with skin1 medium (~180 g)~4.4 g
Almonds28 g~3.5 g
Popcorn, air-popped3 cups (~24 g)~3.5 g
Whole-wheat bread1 slice (~32 g)~2 g

Fiber values and portion weights are USDA FoodData Central standard reference values, rounded.[40]

The arithmetic is unsentimental: one cup of lentils is worth eight slices of whole-wheat bread. A person eating 16 g/day who adds a cup of legumes and a cup of raspberries clears 35 g without touching anything else. Chasing the target through bread, cereal, and "high-fiber" bars is the slow, expensive way to do it.

Titrate up over two to three weeks, and keep your fluids up if they are low. In feeding studies of adults adding half a cup of beans a day, most of those who got wind found it had settled by the second or third week.[41] Going from 16 to 30 g overnight is how people conclude they "can't tolerate fiber," when what they actually did was give their microbiome a fortnight's work in one evening.

When more fiber is the wrong advice

Evidence: Moderate for IBS; Weak for the constipation reversal; Strong that the diverticulitis avoidance advice was wrong.

This section matters, because generic fiber cheerleading does real harm to a minority of readers.

Irritable bowel syndrome. The fermentable fibers — inulin, fructo-oligosaccharides, galacto-oligosaccharides — are FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols), the exact family of short-chain carbohydrates that a low-FODMAP diet strips out to control IBS. Telling someone with IBS to eat more of them is telling them to eat more of their trigger. In a randomized primary-care trial, psyllium relieved IBS symptoms and wheat bran did not — and bran was the arm people quit. Withdrawal for intolerance ran at about twice the placebo rate (18 of 97 on bran, against 9 of 93 on placebo and 7 of 85 on psyllium), and the authors attributed it mainly to symptoms getting worse. Bran did edge ahead of placebo by month three among the roughly half still taking it — a result that disappears once the dropouts are counted as failures — which its authors read as the few it happened to suit.[42] The wider evidence agrees on the practical point: the American College of Gastroenterology suggests soluble but not insoluble fiber for overall IBS symptoms, a strong recommendation on moderate-quality evidence.[43] If you have IBS: viscous, low-fermentation fiber (psyllium, oats) yes; bran and inulin, probably not.

Chronic constipation — sometimes. The reflex is to add fiber. In a study of 63 people with constipation that had no identifiable cause, those who stopped fiber entirely went from a bowel movement every 3.75 days to daily, with bloating and straining resolving completely, while those who went back to high fiber saw no change at all.[44] Take this with real caution. It was not randomized and it was not controlled: everyone was taken off fiber completely for two weeks first, then told to settle wherever they could tolerate, and the "groups" are simply what they were doing six months later — with only six people back on high fiber to compare against. Nobody was blinded, in a study whose outcome was how people said they felt after being told fiber was the problem. But it is enough to justify the clinical rule: if you have added fiber for constipation and it made things worse, believe yourself and stop, rather than adding more. That rule is an exception, not the default. The joint American Gastroenterological Association and American College of Gastroenterology guideline still suggests fiber supplementation for chronic constipation — a conditional recommendation on low-certainty evidence — and the fiber it means is psyllium, which produced global relief in about 390 more people per 1,000 than control, with no serious side effects. It sits below the strongly recommended drugs in that guideline, such as polyethylene glycol, on trials the panel describes as small, old and mostly in women.[45]

Diverticular disease — the myth is dead. For decades, people with diverticulosis were told to avoid nuts, seeds, and popcorn in case fragments lodged in the pouches. Following 47,228 men for 18 years, the highest consumers of popcorn had about 28% lower diverticulitis risk (HR 0.72, 95% CI 0.56–0.92), and nut eaters trended about 20% lower with an interval that just brushed no-effect (HR 0.80, 0.63–1.01). Lower, or at worst unchanged — with no significant increase in any analysis. The authors concluded the avoidance advice "should be reconsidered."[46] It has been. A 2025 cohort of 29,916 women followed for about 14 years, the first to ask the question in women, reached the same place: no excess risk from nuts, seeds or seeded fruit, less risk with corn, and a substantially lower risk on a high-quality overall diet. Its authors' word for the avoidance advice is that their findings "refute" it.[47] Eat the nuts.

Narrowed bowel — the real exception. People with inflammatory bowel disease who have a symptomatic stricture may genuinely not tolerate fibrous plant food, because of its texture rather than its fiber. The gastroenterology advice is to change the texture rather than drop the plants: chew carefully, cook thoroughly, and process fruit and vegetables to a soft consistency. This applies only to symptomatic strictures — people with inflammatory bowel disease in remission and without one are told explicitly that they do not need to limit fiber.[48]

One safety note. Psyllium and the other gel-forming supplement fibers — methylcellulose, glucomannan, guar gum, polycarbophil — swell on contact with water, and taken with too little fluid they can swell in the throat or esophagus rather than the gut, and block it. The warning the US regulator requires on every one of these products has two halves, and the second is the one usually left off: take it with a full glass of liquid, and do not take it at all if you have difficulty swallowing. The risk is also there for anyone with a narrowed or poorly functioning esophagus, independent of how much they drink. Chest pain, vomiting, or difficulty swallowing or breathing after a dose means immediate medical attention.[49]

What's overrated

  • Fiber supplements as disease prevention. No randomized trial shows they prevent disease in ordinary adults, one raised the odds of adenoma recurrence by roughly two-thirds, and WHO deliberately wrote them out of its recommendation. Psyllium is a legitimate tool for lipids, IBS, and bowel regularity — three surrogate jobs it does well. It is not a longevity intervention.
  • Fiber as a "natural Ozempic." It nudges the same fullness hormones, but only for hours, not all week. In the one good long trial, plain fermentable fiber did not match the engineered one on weight gain.
  • "Added fiber" in processed food. Chicory-root inulin sprayed into a protein bar is not what the cohorts measured. The exposure that carried the mortality association was legumes, whole grains, vegetables, fruit, nuts, and seeds — the food matrix, not a number on a label.
  • The exact gram target. Twenty-five grams is a floor derived from an observational curve with no plateau, not a threshold where benefit switches on. Getting from 16 to 25 matters far more than getting from 28 to 30.
  • Fiber as the whole story of carbohydrate quality. It is the better-evidenced marker than glycemic index — that's a claim about certainty, not effect size. See Glycemic index, where the opposing case is presented too.

Bottom line. Eat 25–30 g a day, from legumes, whole grains, vegetables, fruit, nuts, and seeds. The association with living longer is strong, dose-dependent, and about as good as observational nutrition evidence ever gets. Just be honest with yourself about what it is: a very good reason to eat plants, and not a demonstrated causal lever you can buy in a tub.

Further reading

  • Reynolds A, Mann J, et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 2019.[50]
  • World Health Organization. Carbohydrate intake for adults and children: WHO guideline. 2023.[51]
  • Threapleton DE, et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 2013.[52]
  • Aune D, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis. BMJ 2011.[53]
  • Aune D, et al. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality. BMJ 2016.[54]
  • Schatzkin A, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000.[55]
  • Alberts DS, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 2000.[56]
  • Bonithon-Kopp C, et al. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence. Lancet 2000.[57]
  • Yao Y, et al. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2017.[58]
  • Hartley L, et al. Dietary fibre for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2016.[59]
  • Burr ML, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART). Lancet 1989.[60]
  • Howard BV, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative. JAMA 2006.[61]
  • Veronese N, et al. The impact of dietary fiber consumption on human health: an umbrella review of evidence from 17,155,277 individuals. Clin Nutr 2025.[62]
  • Prentice RL, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative. JAMA 2006.[63]
  • Beresford SA, et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative. JAMA 2006.[64]
  • Whitehead A, et al. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2014.[65]
  • Ho HV, et al. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr 2016.[66]
  • Jovanovski E, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2018.[67]
  • Mathers JC, et al. Cancer prevention with resistant starch in Lynch syndrome patients in the CAPP2-randomized placebo controlled trial: planned 10-year follow-up. Cancer Prev Res (Phila) 2022.[68]
  • Lacy BE, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol 2021.[69]
  • Wei ZH, et al. Time- and dose-dependent effect of psyllium on serum lipids. Eur J Clin Nutr 2009.[70]
  • Bijkerk CJ, et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? BMJ 2009.[71]
  • Strate LL, et al. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA 2008.[72]
  • Ho KS, et al. Stopping or reducing dietary fiber intake reduces constipation and its associated symptoms. World J Gastroenterol 2012.[73]
  • Chambers ES, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 2015.[74]

— § —